BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Genetown

  Tremeau Completes $5.2M Equity Raise to Fund Non-Opioid Pain Treatments for Rare Diseases

  The funding will be used to advance Tremeau’s pipeline of non-opioid pain treatment candidates.

  February 15, 2018

   · 

  4 min read
• Policy

  DreaMed Diabetes Receives CE Mark for Platform for the Management of Type 1 Diabetes

  DreaMed Diabetes’ cloud-based solution achieved similar glycemic control to that of medical experts in pilot studies, while simplifying patient experience, by offering a personalized insulin treatment plan based on the analysis of vast amounts of data from a variety of sources.

  February 15, 2018

   · 

  4 min read
• Business

  Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge

  The project aims to develop kallikrein-targeting compounds as novel topical drugs for the rare but severe inflammatory skin disease ‘Netherton Syndrome’ as well as the broader disorder atopic dermatitis.

  February 15, 2018

   · 

  5 min read
• Business

  West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend

  West Pharmaceutical Services today announced its financial results for the fourth-quarter and full-year 2017 and provided financial guidance for full-year 2018.

  February 15, 2018

   · 

  34 min read
• Drug Development

  Evofem Biosciences Completes Enrollment of Phase III Contraceptive Trial of Amphora Ahead of Schedule

  Trial data is expected in the first quarter of 2019.

  February 15, 2018

   · 

  4 min read
• 

  ABAC Therapeutics Announces €16M Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria

  The financing was led by Pontifax with participation from the Global Health Science Fund.

  February 15, 2018

   · 

  3 min read
• Drug Development

  Aravive Biologics Initiates Phase I Study of Novel GAS6-AXL Pathway Inhibitor, AVB-S6-500

  The study is being conducted in the United States and will evaluate safety, pharmacokinetics and pharmacodynamics in approximately 40 healthy volunteers and is designed to demonstrate proof-of-mechanism for the company’s lead drug candidate.

  February 15, 2018

   · 

  4 min read
• Business

  Three-way Collaboration with the U.S. Army, Harvard University and Frequency Therapeutics to Focus on Progenitor Cell Regeneration in Muscle

  The program is focused on small-molecule therapeutics to address several disease indications and conditions involving muscle.

  February 15, 2018

   · 

  6 min read
• Theravance Biopharma Highlights Submission of Landmark IMPACT Data to EMA to Support Expanded Label for Trelegy Ellipta

  If this latest submission is approved, the labeled indication for Trelegy Ellipta would include a wider population of patients with COPD who are at risk of an exacerbation and require triple therapy.

  February 15, 2018

   · 

  7 min read
• Biotech Bay

  Inflammatix Release: New Study Published in ‘Nature Communications’ Suggests Sepsis Can Be Detected By Measuring the Immune System

  Inflammatix announced findings from a new study published today in Nature Communications that suggest that diagnosing and determining who will likely develop sepsis can be improved with a data-driven approach that measures the immune system response to severe infection.

  February 15, 2018

   · 

  4 min read